Financhill
Back

ALX Oncology Holdings Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
34

ALXO
ALX Oncology Holdings

Last Price:
1.50
Seasonality Move:
30.31%
Buy
54

BMRN
Biomarin Pharmaceutical

Last Price:
66.00
Seasonality Move:
14.81%
Sell
34
ALX Oncology Holdings (ALXO) is a Sell

Is ALX Oncology Holdings a Buy, Sell or Hold?

  • The current ALX Oncology Holdings [ALXO] share price is $1.49. The Score for ALXO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • ALXO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $66.00. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ALXO Stock Price Chart

What is ALX Oncology Holdings's stock price today?

  • The ALX Oncology Holdings share price today is $1.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALXO is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $66.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.

ALXO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 40.69 Sell
Chaikin Money Flow: -87896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.43 - 1.69) Sell
Bollinger Bands (100): (1.34 - 5.84) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.93 Sell
Relative Strength Index (14 RSI): 29.43 Sell
Chaikin Money Flow: -205272 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.87 - 70.73) Sell
Bollinger Bands (100): (71.95 - 88.51) Sell

ALXO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.44 Buy
20-day SMA: 1.51 Sell
50-day SMA: 1.85 Sell
200-day SMA: 8.7 Sell
8-day EMA: 1.46 Buy
20-day EMA: 1.55 Sell
50-day EMA: 2.2 Sell
200-day EMA: 6.32 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.17 Sell
20-day SMA: 69.24 Sell
50-day SMA: 75.04 Sell
200-day SMA: 82.85 Sell
8-day EMA: 67.65 Sell
20-day EMA: 69.3 Sell
50-day EMA: 73.55 Sell
200-day EMA: 81.57 Sell

ALX Oncology Holdings Earnings Growth & ALXO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.24 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

ALX Oncology Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):